Company profile: Cerapedics
1.1 - Company Overview
Company description
- Provider of novel osteobiologic medical devices, including the i-FACTOR Peptide Enhanced Bone Graft, a biologic graft of synthetic peptide (P-15) bound to an anorganic bone mineral to support bone growth by enhancing natural healing. Also conducts the ASPIRE IDE pivotal study evaluating a next-generation product for lumbar interbody fusion, which has FDA Breakthrough Device Designation.
Products and services
- ASPIRE IDE Study: FDA Breakthrough Device Designation pivotal study evaluating the use of Cerapedics’ next-generation product in lumbar interbody fusion
- I-FACTOR Peptide Enhanced Bone Graft: Synthetic-peptide-based biologic graft binding P-15 to anorganic bone mineral to enhance natural bone healing and support bone growth
- Osteobiologic Product Development and Commercialization: Osteobiologic-focused initiative that develops and commercializes novel osteobiologic products by Cerapedics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cerapedics
Bonesupport
HQ: Sweden
Website
- Description: Provider of injectable osteoconductive biomaterials for treating fragility fractures from osteoporosis and bone voids or gaps caused by trauma, disease, or surgical procedures. Offers CERAMENT, a range of injectable osteoconductive and drug-eluting bioceramic products for bone voids and fractures that remodel to host bone within six to twelve months.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bonesupport company profile →
RestoreFlow
HQ: United States
Website
- Description: Provider of research into restorative transplantation of donated human tissue for medical treatment, operating in the healthcare industry; incorporated in 2013 and based in Chicago, Illinois.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RestoreFlow company profile →
NuVision Biotherapies
HQ: United Kingdom
Website
- Description: Provider of high-quality, affordable biotherapies for treating front-of-the-eye disease and trauma. A biotechnology research and development spin-out from the University of Nottingham, incorporated in July 2014 to commercialise ophthalmic biotherapies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuVision Biotherapies company profile →
Tepha
HQ: United States
Website
- Description: Provider of a new class of absorbable biomaterials for medical devices, developing and commercializing proprietary polyhydroxyalkanoate technology tailored to meet unmet needs across multiple fields and to be used in surgical procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tepha company profile →
Lamellar
HQ: United Kingdom
Website
- Description: Provider of novel healthcare products based on mimicry or modification of the lamellar body secretory system, leveraging Lamellasomes™ technology and associated intellectual property.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lamellar company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cerapedics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cerapedics
2.2 - Growth funds investing in similar companies to Cerapedics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cerapedics
4.2 - Public trading comparable groups for Cerapedics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →